214 related articles for article (PubMed ID: 33676847)
21. Elevated Expression of N-Acetylgalactosaminyltransferase 10 Predicts Poor Survival and Early Recurrence of Patients with Clear-Cell Renal Cell Carcinoma.
Wu Q; Yang L; Liu H; Zhang W; Le X; Xu J
Ann Surg Oncol; 2015 Jul; 22(7):2446-53. PubMed ID: 25391266
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of FABP7 promotes cell growth and predicts poor prognosis of clear cell renal cell carcinoma.
Zhou J; Deng Z; Chen Y; Gao Y; Wu D; Zhu G; Li L; Song W; Wang X; Wu K; He D
Urol Oncol; 2015 Mar; 33(3):113.e9-17. PubMed ID: 25192834
[TBL] [Abstract][Full Text] [Related]
23. Monocarboxylate transporters MCT1 and MCT4 are independent prognostic biomarkers for the survival of patients with clear cell renal cell carcinoma and those receiving therapy targeting angiogenesis.
Cao YW; Liu Y; Dong Z; Guo L; Kang EH; Wang YH; Zhang W; Niu HT
Urol Oncol; 2018 Jun; 36(6):311.e15-311.e25. PubMed ID: 29657088
[TBL] [Abstract][Full Text] [Related]
24. High expression of interleukin-11 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma.
Pan D; Xu L; Liu H; Zhang W; Liu W; Liu Y; Fu Q; Xu J
Cancer Sci; 2015 May; 106(5):592-7. PubMed ID: 25702890
[TBL] [Abstract][Full Text] [Related]
25. FSIP2 can serve as a predictive biomarker for Clear Cell Renal Cell Carcinoma prognosis.
Zhang Y; Zhu X; Qiao X; Sun L; Tian Y; Yang Y; Zhao Y; Liu C
Int J Med Sci; 2020; 17(17):2819-2825. PubMed ID: 33162809
[No Abstract] [Full Text] [Related]
26. MicroRNA-194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma.
Nofech-Mozes R; Khella HW; Scorilas A; Youssef L; Krylov SN; Lianidou E; Sidiropoulos KG; Gabril M; Evans A; Yousef GM
Cancer Med; 2016 Apr; 5(4):656-64. PubMed ID: 26860079
[TBL] [Abstract][Full Text] [Related]
27. Quantifying rolling adhesion with a cell-free assay: E-selectin and its carbohydrate ligands.
Brunk DK; Hammer DA
Biophys J; 1997 Jun; 72(6):2820-33. PubMed ID: 9168056
[TBL] [Abstract][Full Text] [Related]
28. Expression and prognostic significance of fatty acid synthase in clear cell renal cell carcinoma.
Yuan Y; Yang X; Li Y; Liu Q; Wu F; Qu H; Gao H; Ge J; Xu Y; Wang H; Wang Y; Zhao Z
Pathol Res Pract; 2020 Nov; 216(11):153227. PubMed ID: 33027752
[TBL] [Abstract][Full Text] [Related]
29. Analysis of the nuclear expression of pSer727-STAT3 as a prognostic factor in patients with clear cell renal carcinoma.
Lorente D; Arevalo J; Salcedo MT; Trilla E; de Torres I; Meseguer A; Morote J
Actas Urol Esp (Engl Ed); 2020 May; 44(4):245-250. PubMed ID: 32247519
[TBL] [Abstract][Full Text] [Related]
30. [Role of serum E-selectin (ELAM-1) and inflammatory parameters in patients with renal cell carcinoma].
Muraki J; Kobayashi M; Sugaya Y; Hashimoto S; Morita T; Kobayashi Y; Tokue A
Nihon Hinyokika Gakkai Zasshi; 1996 May; 87(5):831-41. PubMed ID: 8691708
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma.
Shi L; Xiao L; Heng B; Mo S; Chen W; Su Z
Int Urol Nephrol; 2017 Jul; 49(7):1165-1176. PubMed ID: 28349447
[TBL] [Abstract][Full Text] [Related]
32. Concurrent CD44s and STAT3 expression in human clear cell renal cellular carcinoma and its impact on survival.
Qin J; Yang B; Xu BQ; Smithc A; Xu L; Yuan JL; Li L
Int J Clin Exp Pathol; 2014; 7(6):3235-44. PubMed ID: 25031744
[TBL] [Abstract][Full Text] [Related]
33. Proteomic identification of angiomotin by ProteomeLab PF-2D and correlation with clinical outcome in human clear cell renal cell carcinoma.
Yang J; Liu P; Tian M; Li Y; Chen W; Li X
Int J Oncol; 2013 Jun; 42(6):2078-86. PubMed ID: 23588948
[TBL] [Abstract][Full Text] [Related]
34. Expression of monoclonal antibody HECA-452-defined E-selectin ligands on Langerhans cells in normal and diseased skin.
Koszik F; Strunk D; Simonitsch I; Picker LJ; Stingl G; Payer E
J Invest Dermatol; 1994 May; 102(5):773-80. PubMed ID: 7513740
[TBL] [Abstract][Full Text] [Related]
35. PSGL-1 derived from human neutrophils is a high-efficiency ligand for endothelium-expressed E-selectin under flow.
Zou X; Shinde Patil VR; Dagia NM; Smith LA; Wargo MJ; Interliggi KA; Lloyd CM; Tees DF; Walcheck B; Lawrence MB; Goetz DJ
Am J Physiol Cell Physiol; 2005 Aug; 289(2):C415-24. PubMed ID: 15814589
[TBL] [Abstract][Full Text] [Related]
36. Expression of CX3CR1 associates with cellular migration, metastasis, and prognosis in human clear cell renal cell carcinoma.
Yao X; Qi L; Chen X; Du J; Zhang Z; Liu S
Urol Oncol; 2014 Feb; 32(2):162-70. PubMed ID: 23570708
[TBL] [Abstract][Full Text] [Related]
37. Increased expression of MUC1 and sialyl Lewis antigens in different areas of clear renal cell carcinoma.
Borzym-Kluczyk M; Radziejewska I; Cechowska-Pasko M
Clin Exp Nephrol; 2015 Aug; 19(4):732-7. PubMed ID: 25091456
[TBL] [Abstract][Full Text] [Related]
38. A-kinase interacting protein 1 high expression correlates with advanced tumor stage and poor overall survival in surgical patients with clear cell renal cell carcinoma.
Peng H; Zhang R; Zhang H
Medicine (Baltimore); 2020 Jun; 99(24):e20742. PubMed ID: 32541526
[TBL] [Abstract][Full Text] [Related]
39. Golgi Alpha-Mannosidase II as a Novel Biomarker Predicts Prognosis in Clear Cell Renal Cell Carcinoma.
Li C; Guo L; Chen F; Yu W; Rao T; Ruan Y
Oncol Res Treat; 2020; 43(6):264-275. PubMed ID: 32403105
[TBL] [Abstract][Full Text] [Related]
40. A functional glycoproteomics approach identifies CD13 as a novel E-selectin ligand in breast cancer.
Carrascal MA; Silva M; Ferreira JA; Azevedo R; Ferreira D; Silva AMN; Ligeiro D; Santos LL; Sackstein R; Videira PA
Biochim Biophys Acta Gen Subj; 2018 Sep; 1862(9):2069-2080. PubMed ID: 29777742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
